by feryadmin | Nov 9, 2020 | Uncategorized
Eveliqure Biotechnologies GmbH today announces the award of a US government contract from the National Institute of Allergy and Infectious Diseases (NIAID), contract #75N93020C00048 with the intent to fund the development of its vaccine candidate, ShigETEC, through...
by feryadmin | Nov 9, 2020 | Uncategorized
Extremely interesting interview with Dr. Jennifer Doudna, co-developer of the groundbreaking gene editing technology and Nobel Prizer winner in Chemistry this year together with Dr. Emmanuelle Charpentier. During this interview, Dr. Doudna talks in a very clear way...
by feryadmin | Sep 9, 2020 | Uncategorized
Calyxha Biotechnologies GmbH is developing novel therapies targeting #neurodegeneration, the underlying cause of major human diseases, such as Parkinson’s disease. https://www.calyxha.com/
by feryadmin | Jul 9, 2020 | Uncategorized
CEBINA’s drug repurposing project has led to the identification of commonly used drugs with activity against SARS-CoV-2 infection in in vitro assays. https://lnkd.in/eKTJQSY
